⌘K

Home/Filings/4/0001493152-22-014657

4//SEC Filing

Floyd Eric 4

Accession 0001493152-22-014657

CIK 0001708331other

View on SEC.gov Company Profile

Filed

May 19, 8:00 PM ET

Accepted

May 20, 6:12 PM ET

Size

4.5 KB

Accession

0001493152-22-014657

Insider Transaction Report

Form 4

Period: 2022-05-18

Virpax Pharmaceuticals, Inc.VRPX

Director

Transactions

Purchase
Common Stock, $0.00001 par value
2022-05-18$1.36/sh+4,479$6,107→ 8,018 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001818469

Filing Metadata

Form type: 4
Filed: May 19, 8:00 PM ET
Accepted: May 20, 6:12 PM ET
Size: 4.5 KB

View on SEC.gov